Gene · 2119
Papers1,680
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,680
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TAOK3 Facilitates Esophageal Squamous Cell Carcinoma Progression and Cisplatin Resistance Through Augmenting Autophagy Mediated by IRGM. | Adv Sci (Weinh) | 2023 | 37705061 | PubTator, text mining | PubMed |
| Preferential FGF18/FGFR activity in pseudoglandular versus canalicular stage human lung fibroblasts. | Front Cell Dev Biol | 2023 | 37701781 | PubTator, text mining | PubMed |
| Repairing Mechanisms for Distal Airway Injuries and Related Targeted Therapeutics for Chronic Lung Diseases. | Cell Transplant | 2023 | 37698245 | PubTator, text mining | PubMed |
| Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated "Omics" Approaches to Explore Measurable Metrics. | Cancers (Basel) | 2023 | 37686633 | PubTator, text mining | PubMed |
| IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway. | Cancers (Basel) | 2023 | 37686528 | PubTator, text mining | PubMed |
| Real-Time Evaluation of Thyroid Cytology Using New Digital Microscopy Allows for Sample Adequacy Assessment, Morphological Classification, and Supports Molecular Analysis. | Cancers (Basel) | 2023 | 37686491 | PubTator, text mining | PubMed |
| Poly(ADP-ribose) Polyremase-1 (PARP-1) Inhibition: A Promising Therapeutic Strategy for ETS-Expressing Tumours. | Int J Mol Sci | 2023 | 37686260 | PubTator, text mining | PubMed |
| Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma. | Front Immunol | 2023 | 37680641 | PubTator, text mining | PubMed |
| Revealing the developmental origin and lineage predilection of neural progenitors within human bone marrow via single-cell analysis: implications for regenerative medicine. | Genome Med | 2023 | 37667405 | PubTator, text mining | PubMed |
| ETV5 transcriptionally activates TGFβ1 and promotes cancer cell invasion and migration of NSCLC. | J Mol Histol | 2023 | 37656259 | PubTator, text mining | PubMed |
| Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers. | Int J Mol Sci | 2023 | 37628978 | PubTator, text mining | PubMed |
| Targeted Therapy for EWS-FLI1 in Ewing Sarcoma. | Cancers (Basel) | 2023 | 37627063 | PubTator, text mining | PubMed |
| Alveolar type II epithelial cell FASN maintains lipid homeostasis in experimental COPD. | JCI Insight | 2023 | 37606038 | PubTator, text mining | PubMed |
| Gene Ontology Assessment of Indirect Cold Physical Plasma and UV-Radiation Molecular Mechanism at the Cellular Level. | J Lasers Med Sci | 2023 | 37583495 | PubTator, text mining | PubMed |
| Microtubule-Associated Serine/Threonine (MAST) Kinases in Development and Disease. | Int J Mol Sci | 2023 | 37569286 | PubTator, text mining | PubMed |
| Molecular characterization of colorectal adenoma and colorectal cancer via integrated genomic transcriptomic analysis. | Front Oncol | 2023 | 37546388 | PubTator, text mining | PubMed |
| Identifying functional regulatory mutation blocks by integrating genome sequencing and transcriptome data. | iScience | 2023 | 37520692 | PubTator, text mining | PubMed |
| Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1. | Mol Ther Nucleic Acids | 2023 | 37520682 | PubTator, text mining | PubMed |
| Immunoglobulin genes expressed in lymphoblastoid cell lines discern and predict lithium response in bipolar disorder patients. | Mol Psychiatry | 2023 | 37488168 | PubTator, text mining | PubMed |
| USP1 Expression Driven by EWS::FLI1 Transcription Factor Stabilizes Survivin and Mitigates Replication Stress in Ewing Sarcoma. | Mol Cancer Res | 2023 | 37478161 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2119/papers?page=7